Charles Schwab Investment Management Inc Merrimack Pharmaceuticals Inc Transaction History

Charles Schwab Investment Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$12.02 - $13.07 $356,128 - $387,237	29,628 New	29,628 $364,000
Q3 2018 Nov 13, 2018	SELL	$3.91 - $4.66 $115,423 - $137,563	-29,520 Closed	0 $0
Q2 2018 Aug 08, 2018	SELL	$3.86 - $7.61 $92,883 - $183,119	-24,063 Reduced 44.91%	29,520 $145,000
Q1 2018 May 07, 2018	SELL	$6.24 - $9.15 $14,589 - $21,392	-2,338 Reduced 4.18%	53,583 $432,000
Q4 2017 Jan 17, 2018	BUY	$7.99 - $11.87 $16,203 - $24,072	2,028 Added 3.76%	55,921 $574,000
Q3 2017 Nov 13, 2017	BUY	$9.13 - $11.72 $492,043 - $631,625	53,893	53,893 $784,000

437K

Ticker MACK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,410,200
Market Cap $203M
Description
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.